← Back to headlines
Guggenheim Raises AstraZeneca Price Target Ahead of Q1 Earnings
Guggenheim has increased its price target for AstraZeneca's stock in anticipation of the company's upcoming first-quarter earnings report.
30 Mar, 13:58 — 30 Mar, 13:58
Sources
Showing 1 of 1 sources
